Results

Total Results: 5,936 records

Showing results for "stimulants".

  1. cahps.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants
  2. monahrq.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants
  3. teamstepps.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants
  4. ce.effectivehealthcare.ahrq.gov/news/newsletters/e-newsletter/811.html
    April 01, 2022 - stimulant and opioid co-use, such as the Addictions, Drug & Alcohol Institute’s People Who Use Opioids and Stimulants
  5. meps.ahrq.gov/data_files/publications/st277/draft/stat277.shtml
    January 01, 2010 - In 1997, within the gastrointestinal agents therapeutic class, GI stimulants was a first choice therapeutic … In 2007, GI stimulants was not a first choice therapeutic subclass for the MEPS data.
  6. meps.ahrq.gov/data_files/publications/st277/sb277.xml.bak
    January 01, 2010 - In 1997, within the gastrointestinal agents therapeutic class, GI stimulants was a first choice therapeutic … In 2007, GI stimulants was not a first choice therapeutic subclass for the MEPS data.
  7. meps.ahrq.gov/data_files/publications/st277/sb277.xml
    January 01, 2010 - In 1997, within the gastrointestinal agents therapeutic class, GI stimulants was a first choice therapeutic … In 2007, GI stimulants was not a first choice therapeutic subclass for the MEPS data.
  8. meps.ahrq.gov/data_files/publications/st277/stat277.shtml.bak
    January 01, 2010 - In 1997, within the gastrointestinal agents therapeutic class, GI stimulants was a first choice therapeutic … In 2007, GI stimulants was not a first choice therapeutic subclass for the MEPS data.
  9. meps.ahrq.gov/data_files/publications/st277/stat277.pdf
    January 01, 2010 - In 1997, within the gastrointestinal agents therapeutic class, GI stimulants was a first choice therapeutic … In 2007, GI stimulants was not a first choice therapeutic subclass for the MEPS data.
  10. meps.ahrq.gov/data_files/publications/st277/stat277.shtml
    January 01, 2010 - In 1997, within the gastrointestinal agents therapeutic class, GI stimulants was a first choice therapeutic … In 2007, GI stimulants was not a first choice therapeutic subclass for the MEPS data.
  11. srdr.ahrq.gov/projects/592/studies/81947
    January 01, 1997 - Select a Topic: User Home Screen Extraction Forms Project Creation Study Creation Preview Pages Other Your Feedback: Submit Reset Cancel Study Preview Study Title and Description Combined neuromuscular electrical stimulation and …
  12. Sb216-Appendix (pdf file)

    hcup-us.ahrq.gov/reports/statbriefs/sb216-appendix.pdf
    October 01, 2004 - similar cases.) 967.0 Poisoning – analeptics 970.81 Poisoning – other central nervous system stimulants … E854.2 Accidental poisoning by psychostimulants E854.3 Accidental poisoning by central nervous system stimulants … antagonists causing adverse effects in therapeutic use E940.8 Other specified central nervous system stimulants
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_research-protocol.pdf
    January 30, 2014 - stabilizers, anticonvulsants, and psychostimulants.42 Combination therapy with antipsychotics and stimulants … for disruptive behaviors, are alpha-agonists, anticonvulsants, beta-blockers, central nervous system stimulants … antipsychotics, beta-adrenergic blocking agents (i.e., beta-blockers), central nervous system (CNS) stimulants … serotonin reuptake inhibitors"[tiab] OR "Serotonin Uptake Inhibitors" [Pharmacological Action] OR stimulants … [tiab] OR "Central Nervous System Stimulants"[Mesh] OR "Central Nervous System Stimulants" [Pharmacological
  14. pbrn.ahrq.gov/news/newsletters/e-newsletter/866.html
    May 01, 2023 - Trends in dispensed prescriptions for opioids, sedatives, benzodiazepines, gabapentin, and stimulants
  15. pcmh.ahrq.gov/news/newsletters/e-newsletter/866.html
    May 01, 2023 - Trends in dispensed prescriptions for opioids, sedatives, benzodiazepines, gabapentin, and stimulants
  16. www.cahps.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics
  17. www.innovations.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics
  18. www.talkingquality.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics
  19. www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics
  20. www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics